FR2181818B1 - - Google Patents

Info

Publication number
FR2181818B1
FR2181818B1 FR7309153A FR7309153A FR2181818B1 FR 2181818 B1 FR2181818 B1 FR 2181818B1 FR 7309153 A FR7309153 A FR 7309153A FR 7309153 A FR7309153 A FR 7309153A FR 2181818 B1 FR2181818 B1 FR 2181818B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7309153A
Other languages
French (fr)
Other versions
FR2181818A1 (da
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of FR2181818A1 publication Critical patent/FR2181818A1/fr
Application granted granted Critical
Publication of FR2181818B1 publication Critical patent/FR2181818B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7309153A 1972-03-15 1973-03-14 Expired FR2181818B1 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2675972A JPS569511B2 (da) 1972-03-15 1972-03-15

Publications (2)

Publication Number Publication Date
FR2181818A1 FR2181818A1 (da) 1973-12-07
FR2181818B1 true FR2181818B1 (da) 1976-07-02

Family

ID=12202194

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7309153A Expired FR2181818B1 (da) 1972-03-15 1973-03-14

Country Status (8)

Country Link
JP (1) JPS569511B2 (da)
CA (1) CA1049504A (da)
CH (1) CH590290A5 (da)
DE (1) DE2312976A1 (da)
FR (1) FR2181818B1 (da)
GB (1) GB1409177A (da)
HU (1) HU168866B (da)
NL (1) NL7303660A (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208171A1 (es) * 1972-09-29 1976-12-09 Ciba Geigy Ag Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
JPS587637B2 (ja) * 1973-12-27 1983-02-10 住友化学工業株式会社 シンキペニシリンノ セイホウ
US3954734A (en) * 1974-01-21 1976-05-04 Parke, Davis & Company Novel antibacterial amide compounds and process means for producing the same
JPS5761760B2 (da) * 1974-02-04 1982-12-25 Sumitomo Chemical Co
JPS5346997A (en) * 1976-10-06 1978-04-27 Bristol Myers Co Antiibacterial agent
JPS54119484A (en) * 1978-03-07 1979-09-17 Mitsui Toatsu Chem Inc Novel penicillin and antibracterial containing the same as the active ingredient
JPS55111489A (en) * 1979-02-19 1980-08-28 Eisai Co Ltd Penicillin derivative, its preparation, and antibacterial agent comprising it
JPS55120566A (en) * 1979-03-09 1980-09-17 Mitsui Toatsu Chem Inc New quinoline derivative
US4231928A (en) * 1979-04-24 1980-11-04 Bristol-Myers Company Antibacterial agents
JPS57129218U (da) * 1981-02-09 1982-08-12
JPS57168819U (da) * 1981-04-20 1982-10-23
JPH0110726Y2 (da) * 1981-05-12 1989-03-28
JPS5875309U (ja) * 1981-11-13 1983-05-21 東芝電池株式会社 自走式レコ−ドクリ−ナ−

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4872189A (da) * 1971-12-29 1973-09-29
JPS5017994A (da) * 1973-06-19 1975-02-25

Also Published As

Publication number Publication date
CH590290A5 (da) 1977-07-29
FR2181818A1 (da) 1973-12-07
GB1409177A (en) 1975-10-08
HU168866B (da) 1976-07-28
JPS569511B2 (da) 1981-03-02
JPS4892391A (da) 1973-11-30
CA1049504A (en) 1979-02-27
DE2312976A1 (de) 1973-09-27
NL7303660A (da) 1973-09-18

Similar Documents

Publication Publication Date Title
FR2201075B1 (da)
HU168866B (da)
JPS5241439B2 (da)
BG18674A1 (da)
BG19349A1 (da)
BG19658A1 (da)
BG19955A1 (da)
BG20008A1 (da)
BG20469A1 (da)
BG20480A1 (da)
CH1348472A4 (da)
CH249173A4 (da)
CH533572A4 (da)
CH559993A5 (da)
CH560410A (da)
CH561670A5 (da)
CH563237A5 (da)
CH565246A5 (da)
CH565301A5 (da)
CH566815A5 (da)
CH567003A5 (da)
CH567592A5 (da)
CH567700A5 (da)
CH567780A5 (da)
CH567874A5 (da)

Legal Events

Date Code Title Description
ST Notification of lapse